EP Patent

EP3237388B1 — N-methyl-n-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the kappa opioid receptor

Assigned to Nektar Therapeutics · Expires 2019-07-03 · 7y expired

What this patent protects

Patent listed against naloxegol-oxalate.

Drugs covered by this patent

naloxegol-oxalate (NALOXEGOL OXALATE)

Patent Metadata

Patent number: EP3237388B1
Jurisdiction: EP
Classification: —
Expires: 2019-07-03
Drug substance claim: No
Drug product claim: No
Assignee: Nektar Therapeutics
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.